A comprehensive view of Prescription Drugs. This page highlights a small sample of our full coverage.
For real-time access, please log in to your R&D/Patents Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

Kaiser Health News reports government-funded courses of Pfizer’s Paxlovid antiviral expected to run out in a few months, cutting access to the treatment to the uninsured and seniors; about 6 million people have take Paxlovid in US

Eli Lilly and Boehringer Ingelheim report diabetes drug Jardiance empagliflozin significantly reduced average blood sugar in children, adolescents with type 2 diabetes in a late-stage study

GSK releases statement regarding Zantac ranitidine litigation

Pfizer faces lawsuit that alleges it knew Chantix contained probable human carcinogen N-nitroso-varenicline and other nitrosamines that can cause tumors, liver, kidney damage; lawsuit filed in US District Court for Eastern District of Washington

US District Court finds nearly 50,000 lawsuits against GSK, Pfizer, Sanofi, Boehringer Ingelheim alleging heartburn drug Zantac causes cancer not backed by sound science; tens of thousands of similar cases are pending in state courts across US

Ask us about our R&D/Patents market view

Trending Chart

Interactive chart with headline count